Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
2966664 | Journal of Clinical Lipidology | 2008 | 11 Pages |
Abstract
The greater efficacy related to changes in blood lipids of EZE/SIMVA compared with both ATORVA and ROSUVA extends to changes in many emerging risk factors. Ultimate clinical implications of these findings still need to be defined.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Michael H. MD, Nicola MD, Christie M. MD, Alberico L. PhD, Xia PhD, Jianxin MS, Elizabeth PhD, Andrew M. MD, MPH,